Drugs / iNO
last change May 2017 re-read 3 minutes ago

iNO

Developed for
respiratory distress syndrome in premature infants
Investigated by
Mallinckrodt · University of Oklahoma

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
— NCT01220687 Apr 2011 → Jan 2017 respiratory distress syndrome in premature infants University of Oklahoma Completed Met primary

Evidence & citations 2 cited values

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as iNO ClinicalTrials.gov intervention name — accepted as the source's own label NCT01220687 ↗
Route Inhaled “inhaled nitric oxide (iNO) will be used as an adjunct to oxygen” NCT01220687 ↗